학술논문
92P First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S396-S397
Subject
Language
ISSN
0923-7534